Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZC3H6 Inhibitors

Chemical inhibitors of ZC3H6 include various compounds that modulate cellular signaling pathways, each with a distinct mechanism of action that can lead to the inhibition of ZC3H6 function. Apigenin, for example, targets multiple protein kinases and can reduce the phosphorylation of proteins, which may include ZC3H6 or its regulatory proteins, affecting its role in RNA metabolism. Similarly, LY294002 and Wortmannin are both phosphoinositide 3-kinase (PI3K) inhibitors, which act on the PI3K/Akt signaling pathway that is integral to various cellular functions. By inhibiting this pathway, these compounds can alter the cellular environment and indirectly affect the function of ZC3H6, especially in contexts where cellular growth and survival signals are involved.

Further inhibitors that can affect the function of ZC3H6 include GW5074 and U0126, which target components of the MAPK/ERK pathway. GW5074 inhibits Raf-1 kinase, while U0126 and PD98059 are selective inhibitors of MEK. Both pathways converge on the phosphorylation and activation of ERK, influencing gene expression and potentially impacting the regulatory roles of ZC3H6 in mRNA processing and stability. SB203580 and SP600125 inhibit other MAPK family members, p38 MAP kinase, and c-Jun N-terminal kinase (JNK), respectively. By inhibiting these kinases, SB203580 and SP600125 can alter stress responses and cytokine production or transcription and apoptotic responses. These changes can indirectly influence the functional landscape in which ZC3H6 operates, particularly in relation to cellular stress responses or apoptosis-related RNA processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Apigenin

520-36-5sc-3529
sc-3529A
sc-3529B
sc-3529C
sc-3529D
sc-3529E
sc-3529F
5 mg
100 mg
1 g
5 g
25 g
100 g
1 kg
$33.00
$214.00
$734.00
$1151.00
$2348.00
$3127.00
$5208.00
22
(1)

Apigenin is a flavonoid that has been shown to inhibit various protein kinases. ZC3H6 is known to be regulated by phosphorylation, which could be modulated by kinases. By inhibiting these kinases, Apigenin can lead to reduced phosphorylation of ZC3H6, which may result in the functional inhibition of ZC3H6's role in RNA metabolism.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a potent inhibitor of phosphoinositide 3-kinases (PI3K). PI3K signaling is crucial for many cellular processes, including growth and survival. While ZC3H6 is not directly involved in the PI3K pathway, the downstream effects of PI3K inhibition could potentially alter the cellular environment in a way that inhibits the function of ZC3H6, particularly if ZC3H6's function is linked to cellular growth pathways or survival mechanisms that are PI3K-dependent.

GW 5074

220904-83-6sc-200639
sc-200639A
5 mg
25 mg
$106.00
$417.00
10
(1)

GW5074 is an inhibitor of Raf-1 kinase, an enzyme upstream of the MAPK/ERK signaling pathway. The MAPK/ERK pathway is involved in the regulation of gene expression and cell cycle. Inhibition of this pathway could potentially influence cellular processes that rely on the function of ZC3H6, such as mRNA processing and stability, thereby inhibiting ZC3H6 function indirectly through alteration of the transcriptional landscape and mRNA dynamics that ZC3H6 would normally regulate.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is a selective inhibitor of MEK, which acts downstream of Raf-1 in the MAPK/ERK pathway. MEK inhibition can reduce the phosphorylation and activation of ERK, leading to alterations in gene expression that could suppress the functions of proteins involved in RNA metabolism, including ZC3H6. As ZC3H6 is implicated in post-transcriptional gene regulation, its function could be indirectly inhibited through the suppression of the MAPK/ERK pathway, which may regulate proteins and processes that ZC3H6 interacts with.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a well-known inhibitor of p38 MAP kinase, which is involved in the response to stress stimuli and is part of the MAPK signaling pathway. By inhibiting p38 MAP kinase, SB203580 can lead to changes in stress response and cytokine production, which could indirectly inhibit ZC3H6 by altering the cellular responses and pathways that ZC3H6 may regulate or be involved in, particularly if ZC3H6 functions are stress-responsive or are modulated by cytokine signaling.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), another member of the MAPK family. JNK plays a role in the control of gene expression and apoptosis. The inhibition of JNK can lead to altered transcription and apoptotic responses, which could indirectly inhibit ZC3H6 if ZC3H6 functions are connected to the pathways regulated by JNK, such as cellular stress responses or apoptosis-related mRNA processing and stabilization.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a MEK inhibitor, similar to U0126, which blocks the activation of downstream ERK. By inhibiting MEK and consequently reducing ERK activity, PD98059 can lead to downstream effects on gene expression and mRNA stability, which may indirectly inhibit ZC3H6 functions that are dependent on or regulated by the MAPK/ERK pathway's control of gene expression.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent PI3K inhibitor, similar to LY294002, and acts to inhibit the PI3K/Akt signaling pathway. Inhibition of this pathway can affect a multitude of cellular processes, including growth, survival, and metabolism, which could in turn indirectly inhibit the function of ZC3H6 by changing the cellular environment and affecting pathways or processes that ZC3H6 is involved in or regulates, particularly in the context of cellular responses to growth and survival signals.